Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention.
Kereiakes DJ, Broderick TM, Roth EM, Whang D, Shimshak T, Runyon JP, Hattemer C, Schneider J, Lacock P, Mueller M, Abbottsmith CW. Kereiakes DJ, et al. Among authors: runyon jp. Am J Cardiol. 1999 Aug 15;84(4):391-5. doi: 10.1016/s0002-9149(99)00321-5. Am J Cardiol. 1999. PMID: 10468074 Clinical Trial.
IIb's are not IIb's.
Kereiakes DJ, Runyon JP, Broderick TM, Shimshak TM. Kereiakes DJ, et al. Among authors: runyon jp. Am J Cardiol. 2000 Apr 27;85(8A):23C-31C. doi: 10.1016/s0002-9149(00)00876-6. Am J Cardiol. 2000. PMID: 10793177
Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: an algorithm for percutaneous management.
Dippel EJ, Kereiakes DJ, Tramuta DA, Broderick TM, Shimshak TM, Roth EM, Hattemer CR, Runyon JP, Whang DD, Schneider JF, Abbottsmith CW. Dippel EJ, et al. Among authors: runyon jp. Catheter Cardiovasc Interv. 2001 Mar;52(3):279-86. doi: 10.1002/ccd.1065. Catheter Cardiovasc Interv. 2001. PMID: 11246236
Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet Glycoprotein IIb/IIIa receptor blockade with oral xemilofiban: results of a multicenter, placebo-controlled, randomized trial.
Kereiakes DJ, Kleiman NS, Ferguson JJ, Masud AR, Broderick TM, Abbottsmith CW, Runyon JP, Anderson LC, Anders RJ, Dreiling RJ, Hantsbarger GL, Bryzinski B, Topol EJ. Kereiakes DJ, et al. Among authors: runyon jp. Circulation. 1998 Sep 29;98(13):1268-78. doi: 10.1161/01.cir.98.13.1268. Circulation. 1998. PMID: 9751674 Clinical Trial.
Extensive thrombus prior to elective percutaneous coronary intervention.
Kandzari DE, Behar VS, Sketch MH Jr, Kereiakes DJ, Shimshak T, Broderick T, Young J, Runyon JP, Safian RD, Kern M, Colombo A. Kandzari DE, et al. Among authors: runyon jp. J Invasive Cardiol. 2001 Jul;13(7):538-42. J Invasive Cardiol. 2001. PMID: 11435643 No abstract available.
20 results